Next Article in Journal
Antimicrobial Peptides in Reptiles
Next Article in Special Issue
The Medicinal Chemistry of Imidazotetrazine Prodrugs
Previous Article in Journal / Special Issue
Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Conformational Analysis, Molecular Structure and Solid State Simulation of the Antiviral Drug Acyclovir (Zovirax) Using Density Functional Theory Methods

by
Margarita Clara Alvarez-Ros
and
Mauricio Alcolea Palafox
*
Departamento de Química-Física I. Facultad de Ciencias Químicas, Universidad Complutense, Ciudad Universitaria, Madrid 28040, Spain
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2014, 7(6), 695-722; https://doi.org/10.3390/ph7060695
Submission received: 16 January 2014 / Revised: 22 May 2014 / Accepted: 26 May 2014 / Published: 6 June 2014
(This article belongs to the Special Issue Prodrugs: from Design to Clinic)

Abstract

:
The five tautomers of the drug acyclovir (ACV) were determined and optimised at the MP2 and B3LYP quantum chemical levels of theory. The stability of the tautomers was correlated with different parameters. On the most stable tautomer N1 was carried out a comprehensive conformational analysis, and the whole conformational parameters (R, β, Φ, φ1, φ2, φ3, φ4, φ5) were studied as well as the NBO Natural atomic charges. The calculations were carried out with full relaxation of all geometrical parameters. The search located at least 78 stable structures within 8.5 kcal/mol electronic energy range of the global minimum, and classified in two groups according to the positive or negative value of the torsional angle φ1. In the nitrogen atoms and in the O2' and O5' oxygen atoms of the most stable conformer appear a higher reactivity than in the natural nucleoside deoxyguanosine. The solid state was simulated through a dimer and tetramer forms and the structural parameters were compared with the X-ray crystal data available. Several general conclusions were emphasized.

1. Introduction

Acyclovir (ACV, 9-(2-hydroxyethoxymethyl) guanine, Zovirax [1,2], Figure 1), is a guanine derivative possessing antiviral activity and commonly used in the treatment of herpes. It is a potent antiviral agent that is used as a highly specific inhibitor of herpes viruses (HSV) types 1 and 2 [3,4,5,6,7]. A series of new guanine base modified tricyclic analogues of ACV and ganciclovir were evaluated for activity against herpes simplex virus type 1 and 2, showing similar antiherpetic potency as the parent compounds ACV and ganciclovir [8]. The antiherpetic activity was found to be strongly dependent on the nature and esteric demands of the substituents in the 6 and/or 7 positions [9].
Figure 1. Molecular structure and definition of the torsional angles in tautomer N1 of acyclovir.
Figure 1. Molecular structure and definition of the torsional angles in tautomer N1 of acyclovir.
Pharmaceuticals 07 00695 g001
Most persons who are infected with human immunodeficiency virus type (HIV-1) are also infected with herpes simplex type2 (HSV-2), which is associated with increased plasma and genital levels of HIV-1. Thus, it has been reported that ACV inhibits HIV upon human herpes virus (HHV) coinfection in tissue cultures. This activity was found to be correlated with the phosphorylation of the parent drug to the monophosphate form mediated by HHV-encoded kinase [10]. Recent studies show that ACV decreases the HIV-1 RN and suppress both viruses in coinfected tissues [11], with great impact on HIV and HSV-2 seropositive patients [12,13]. The treatment of ACV- resistant HSV infections [7,14] and tests for release it at oral therapeutic levels have been also reported [15].
As it is shown above, ACV has been extensively studied from the pharmaceutical and medical point of view. However, few studies appear on its molecular structure, only at low level [16], and to our knowledge, there is no data on its conformational characteristics by Density Functional Methods (DFT) or ab initio quantum chemical methods. Thus, it is one of the tasks of the present manuscript. Conformations of some derivatives of ACV with biological activities have been reported [17], as well as studies of complexes of ACV with several metals [18,19].
The tautomeric study of DNA structural components has a great interest today with numerous research publications [20,21]. The tautomeric equilibrium in ACV between the keto and enol forms has been observed from the UV/VIS spectra [22]. This equilibrium depends on the polarity of the solvent, and therefore, in water solution the keto form prevails, while in methylene chlorides it is the enol one. Thus, another goal of the present manuscript is to study the possible tautomers of ACV, and the determination of their % populations at room temperature and at 273.15 K. The stability of these tautomers and its dependence of different parameters is another point analyzed here.
Finally, from our understanding, would be interesting to calculate the different conformational possibilities of ACV and compare the results with the natural nucleoside deoxyguanosine (dG). This is the last goal of the present manuscript. An accurate knowledge of the different conformers of ACV, its charge distribution, inter- and intra-molecular interactions, solid structure, and flexibility would be an important help for the interpretation of drug-target interactions, as well as to design new antivirus.
For this reason, the conformers of natural and analogues nucleosides have been analyzed by different authors. Now, an extensive theoretical study of the conformational preferences in ACV has been carried out with full relaxation of all geometric parameters, in an attempt to gain insights into molecular features responsible for activity. We will attempt to determine herein, if the various geometric features in ACV are correlated or interact with one another. We are also interested in whether alternative forms of hydrogen bonding make significant contributions to the conformational behavior of ACV.

2. Computational Details

Calculations were carried out by using the Becke exchange functional (B) [23], Becke’s three-parameter exchange functional (B3) [24], Handy’s OPTX modification of Becke’s exchange functional (O) [25,26] and the extended (X3) [27], in combination with the correlation functionals of Lee, Yang, and Parr (LYP) [28], and Perdew and Wang’s 1991 (PW91) [29]. B3LYP Density Functional method (DFT) is the most used today, and for this reason the majority of the calculations were carried out with it.
All the methods appear implemented in the GAUSSIAN 03 program package [30]. The UNIX version with standard parameters of this package was used in the alpha computer of the Computational Centre from University Complutense of Madrid, in which all quantum chemical computations were performed. DFT methods provide adequate compromise between the desired accuracy and the heavy demands put on computer time and power. Different studies have shown that the data obtained with DFT methods are in good agreement with those obtained by expensive computational methods as MP2 [31,32,33,34,35]. Also they give good results in many studies on nucleosides and on drug design [36,37] and they predict vibrational frequencies of DNA bases better than HF and MP2 [38,39,40,41,42]. Moreover, because of the high size of ACV, MP2 calculations were only possible with the 6–31G(d) basis set for memory computer problems. However, we used the 6–31G(d,p) basis to calculate single point energies.
The 3D Potential Energy Surface (PES) of this molecule was determined by rotation of the exocyclic and endocyclic torsional angles φ1 (equivalent to χ angle in nucleosides [43]), φ2, φ3, φ4 and φ5. These dihedral angles were simultaneously hold fixed at values varying between 0° and 360° in steps of 60° in a first study. All other geometrical parameters were relaxed during these optimizations. 78 optimized geometries were obtained in this step by minimizing the energy with respect to all geometrical parameters without imposing molecular symmetry constraints. Berny optimizations under the TIGHT criterion were used. Atomic charges were determined with the Natural NBO procedure [44].
Harmonic wavenumber computations were carried out at the same level of the respective optimization process and by the analytic evaluation of the second derivative of the energy with respect to nuclear displacement. Vibrational frequencies calculations were performed on all optimized conformers to confirm that they corresponded to local minima. All optimized structures showed only positive harmonic vibrations (local energy minima). Relative energies were obtained by adding zero-point vibrational energies (ZPEs) to the total energy. For the calculation of the ZPEs, the frequencies were retained unscaled. The ΔG values were sums of electronic and thermal Free Energies. The conformational equilibrium at 298.15 K was evaluated by means of the Boltzmann distribution formula exp(−ΔG/kT), where ΔG is the relative Gibbs energy.

3. Results and Discussion

ACV has five possible tautomers (Figure 2), that were fully optimized at different levels of computation, Table 1. The most stable one corresponds to N1, and thus we have focused the study only in this tautomer. The remaining forms were left for future research. In the last two column of this Table is shown the % population of the different tautomers at 298.15 K and 273.15 K. At room temperature the largest population corresponds to tautomer N1 (48.1%). The second population is due to OHC tautomer (37.7%) and the third one is to OHT (14.3%). Tautomers N3 and N7 have very little population, less than 0.05%.
Figure 2. Five tautomers described in acyclovir.
Figure 2. Five tautomers described in acyclovir.
Pharmaceuticals 07 00695 g002
Table 1. The optimum stable tautomers calculated in acyclovir molecule at the levels: B3LYP/6-311++G(3df,pd) (values in bold); MP2/6-31G(d,p) (values in key); B3LYP/6-31G(d,p) (values in normal); O3LYP/6-31G(d,p) (values in brackets); B3PW91/6-31G(d,p) (values in parenthesis); B3LYP/cc-pVDZ (values in quotation marks) and B972/6-31G(d,p) (values in italic type). Torsional angles in degrees, dipole moments in debyes, distance R in Å, energy increments in kcal·mol−1 and population (%) at 298.15 K (P298.15) and at 273.15 K (P273.15).
Table 1. The optimum stable tautomers calculated in acyclovir molecule at the levels: B3LYP/6-311++G(3df,pd) (values in bold); MP2/6-31G(d,p) (values in key); B3LYP/6-31G(d,p) (values in normal); O3LYP/6-31G(d,p) (values in brackets); B3PW91/6-31G(d,p) (values in parenthesis); B3LYP/cc-pVDZ (values in quotation marks) and B972/6-31G(d,p) (values in italic type). Torsional angles in degrees, dipole moments in debyes, distance R in Å, energy increments in kcal·mol−1 and population (%) at 298.15 K (P298.15) and at 273.15 K (P273.15).
TautomersRβΦφ1φ2φ3φ4φ5μΔEΔGP298.15P273.15
N13.96372.554.3−75.3146.4−88.569.8−69.35.7390 a
{3.892}{73.5}{51.3}{−71.9}{150.3}{−94.6}{69.1}{−75.4}{6.207}{0} b
3.92572.353.7−74.1144.7−93.471.1−73.35.3750 c0 d48.149.2
[3.956][72.7][53.9][−75.4][144.5][−94.0][71.5][−72.1][5.369][0] e[0.638] f
(3.891)(72.7)(53.2)(−75.1)(145.2)(−92.3)(70.3)(−74.1)(5.492)(0) g(0) h
“3.922”“72.0”“54.0”“−73.9”“143.2”“−92.0”“72.3”“−74.4”“5.34”“0” i “0” j
3.91372.853.375.0145.393.470.873.65.5020 k0 l
N3{3.672}{77.0}{53.5}{−45.9}{149.1}{−92.5}{60.2}{−92.6}{12.220}{25.457}
3.87780.549.5−48.4155.0−93.961.1−88.11.18325.52924.811<0.05<0.05
N7{3.741}{73.0}{52.0}{−76.4}{140.5}{−80.8}{72.4}{−92.7}{9.841}{19.302}
3.74572.853.3−79.9136.9−78.571.8−91.57.78517.51617.689<0.05<0.05
OHC{3.826}{73.5}{51.7}{−72.3}{146.5}{−89.2}{70.4}{−82.6}{2.471}{0.603}
3.83972.953.4−75.9141.9−87.071.1−81.52.1000.1450.28437.737.7
OHT{3.792}{73.5}{52.0}{−72.4}{145.0}{−87.2}{70.6}{−86.1}{3.437}{1.131}
3.80672.953.6−76.2140.7−85.071.0−84.92.1050.7190.830 14.313.1
a ΔE = 0 = −811.214731 a.u. at B3LYP/6-311++G(3df,pd) level; b ΔE = 0 = −808.643998 a.u. at MP2/6-31G(d,p) level; c ΔE = 0 = −810.723396 a.u. at B3LYP/6-31G(d,p) level; d ΔG = 0 = −810.764701 a.u.; e ΔE = 0 = −810.449499 a.u. at O3LYP/6-31G(d,p) level; f ΔG = 0 = −810.490782 a.u.; g ΔE = 0 = −810.419555 a.u. at B3PW91/6-31G(d,p) level; h ΔG = 0 = −810.460766 a.u.; i ΔE = 0 = −810.760402 a.u. at B3LYP/cc-pVDZ level; j ΔG = 0 = −810.801662 a.u.; k ΔE = 0 = −810.444324 a.u. at B972/6-31G(d,p) level; l ΔG = 0 = −810.485454 a.u.
An analysis of the relative energies of these tautomers shows that they can be related to the dipole moment (μ) and to the torsional angle φ1, Figure 3. Thus, the least stable tautomer in the isolated state (N7) has the highest μ, i.e., it is the most stable in water solution. Other relations can be observed between ΔE and φ1. It is noted that tautomer N7 has the highest negative value of φ1 angle.
Figure 3. Relationship/tendency observed between the relative electronic energy ΔE + ZPE correction of the different tautomers vs. (a) the dipole moment μ. and (b) the exocyclic torsional angle φ1.
Figure 3. Relationship/tendency observed between the relative electronic energy ΔE + ZPE correction of the different tautomers vs. (a) the dipole moment μ. and (b) the exocyclic torsional angle φ1.
Pharmaceuticals 07 00695 g003

3.1. Definition of the Conformational Angles

The atomic description of tautomer N1 of ACV, as well as the most important exocyclic and endocyclic torsional angles, is defined in Figure 1. The conformation can be characterized by the following five torsional angles: (i) the torsional angle, φ1(C4-N9-C1'-O2'), which determines the two orientations of the base relative to the opened chain, denoted in the present manuscript as conformers A and B; (ii) The exocyclic torsional angle φ2 (N9-C1'-O2'-C3'); (iii) φ3 (C1'-O2'-C3'-C4') that determine the different folds of the chain; (iv) φ4 (O2'-C3'-C4'-O5') describing the O5'H orientation; and (v) the torsional angle φ5 (C3'-C4'-O5'-H5') that define the orientation of the hydroxyl hydrogen H5'. This φ5 angle has some similarities with the β angle of the nucleosides [43].
Considering the structure of the chain, that likes the structure of the sugar in the nucleosides, and in accordance to previous works [45], other three structural parameters were defined to fix the chain position respect to the plane of the nucleobase: (vi) The vector R (N9···O5') which determines the distance of the OH group relative to the base; (vii) The angle β (C4-N9···O5') which defines the angle of the OH group relative to the base plane; and (viii) the angle Φ (C1'-N9···O5') which also determines the position of the OH group.

3.2. Conformers and Energetics

An extensive conformational study of tautomer N1 was carried out through a rotation of the exocyclic φ1, φ2, φ3, φ4 and φ5 torsional angles. A detailed collection of the most important conformational parameters of these optimized forms is included in Table 2. The conformers were classified according to the two ranges of rotation of φ1: conformers A with the φ1 values negative and conformers B with φ1 positive.
Two energy criteria were considered for each conformer: the electronic energy ΔE + ZPE correction, and the Gibbs energy ΔG. For the numbering of the conformers in each range of rotation of φ1 was followed the ΔE + ZPE criterion. Calculations at different levels, as well as single point calculations at the MP2/6-31G(d,p)//B3LYP/6-31G(d,p) level were carried out to confirm the stability of the main conformers, Table 2 and Table 3. In general, the stability order remains, although several changes are observed. Thus, conformer B2 appears as the most stable one instead of A1 predicted by the DFT methods. The % population of the different conformers at 298.15 K (P298.15) and at 273.15 K (P273.15) was calculated. It indicates that only confomers A1 (41.5%), B1 (36.1%), B2 (9.6%) and A2 (8.7%) have importance. The population of the remaining conformers is lower than 1% and thus they are not of interest. The temperature effect is not significant.
By the same methodology, the relative energies of the different conformers have been determined in related nucleosides [34,46,47,48]. The global minimum calculated in these molecules by MP2/6-31G(d,p) was in accordance to that found by B3LYP/6-31G(d,p). Thus, our results by B3LYP can be considered acceptable.
Table 2. The 78 optimum stable conformers calculated in tautomer N1 of acyclovir molecule at the levels: B3LYP/6-311++G(3df,pd) (values in bold); MP2/6-31G(d) (values in keys); B3LYP/6-31G(d,p) (values in normal type); O3LYP/6-31G(d,p) (values in brackets); B3PW91/6-31G(d,p) (values in parenthesis); B3LYP/cc-pVDZ (values in quotation marks) and B972/6-31G(d,p) (values in italic type) level. Distance R in Å, torsional angles in degrees, dipole moments in debyes, and energy increments in kcal·mol−1.
Table 2. The 78 optimum stable conformers calculated in tautomer N1 of acyclovir molecule at the levels: B3LYP/6-311++G(3df,pd) (values in bold); MP2/6-31G(d) (values in keys); B3LYP/6-31G(d,p) (values in normal type); O3LYP/6-31G(d,p) (values in brackets); B3PW91/6-31G(d,p) (values in parenthesis); B3LYP/cc-pVDZ (values in quotation marks) and B972/6-31G(d,p) (values in italic type) level. Distance R in Å, torsional angles in degrees, dipole moments in debyes, and energy increments in kcal·mol−1.
ConformersRβ aΦ aφ1φ2φ3φ4φ5μΔEΔG
A13.96372.554.3−75.3146.4−88.569.8−69.35.7390 b
{2.859}{73.8}{50.9}{−71.8}{151.8}{−96.3}{68.8}{−74.2}{6.182}{0.064}
3.92572.353.7−74.1144.7−93.471.1−73.35.3750 c0 d
[3.956][72.7][53.9][−75.4][144.5][−94.0][71.5][−72.1][5.369][0] e[0.638]
(3.891)(72.7)(53.2)(−75.1)(145.2)(−92.3)(70.3)(−74.1)(5.492)(0) f(0) g
“3.922”“72.0”“54.0”“−73.9”“143.2”“−92.0”“72.3”“−74.4”“5.343”“0” h“0” i
3.91372.853.375.0145.393.470.873.65.5020 j0 k
A23.77476.852.5−97.765.974.6−67.0−34.15.3671.258
{3.727}{77.7}{50.7}{−96.9}{66.0}{76.2}{−65.5}{−42.7}{5.776}{0.095}
2.89277.351.5−97.067.772.4−65.1−39.35.3820.9281.324
[3.779][77.9][51.3][−98.8][68.1][72.8][−65.5][−38.3][5.361][1.189][2.009]
(3.715)(77.0)(51.6](−97.4)(67.4)(72.8)(−65.4)(−38.6)(5.436)(0.655)(1.034)
“3.730”“77.1”“51.6”“−96.6”“67.6”“72.4”“−64.9”“−38.4”“5.385”“1.000”“1.370”
3.73677.451.597.967.473.265.538.75.4381.0001.018
A35.155118.537.5−107.771.0171.1−63.757.65.7621.202
{5.004}{111.4}{37.6}{−101.9}{64.7}{164.9}{−61.1}{53.9}{5.586}{2.240}
5.104118.636.4−108.569.9168.3−61.153.45.5942.3031.014
[5.149][121.2][36.1][−112.1][71.9][168.7][−63.0][55.9][5.653][0.585][0.073]
(5.079)(119.1)(36.8)(−110.2)(69.3)(168.7)(−60.9)(52.4)(5.702)(1.795)(0.553)
“5.105”“120.0”“36.7”“−109.9”“71.0”“169.9”“−60.7”“52.5”“5.610”“2.864”“1.513”
5.094119.136.7110.069.6168.661.954.85.6732.8640.095
A44.592116.264.7−106.073.2178.665.0−56.87.6301.726
{4.487}{113.4}{64.9}{−100.7}{67.1}{178.0}{61.3}{−52.8}{8.026}{2.887}
4.517117.565.1−106.771.7−179.562.2−52.97.3902.7651.457
[4.552][119.3[65.0][−109.9][73.7][−179.3][64.3][−55.3][7.309][1.030][0.432]
(4.500)(118.5)(65.1)(−107.9)(71.0)(−179.6)(62.0)(−52.8)(7.480)(2.309)(1.009)
“4.500”“117.5”“65.1”“−107”“71.0”“−179.6”“62.0”“−52.8”“7.480”“3.256”“1.871”
4.515118.465.1108.271.4179.762.954.07.4673.2560.503
A55.119123.336.2−81.4−71.2−170.160.7−53.65.1662.9521.976
A64.839130.350.2−93.9−178.3174.3−60.654.47.3873.8702.472
A74.342110.769.0−100.573.3−114.2−57.053.34.3424.0882.821
A85.31499.161.8−108.870.2174.4179.8123.15.4904.5293.020
A94.31672.329.9−100.986.994.8−69.7165.38.4014.5403.284
A104.31798.829.8−100.487.162.4118.4−119.68.4024.5413.295
A114.31698.829.8−100.587.194.7−69.8165.68.4034.5413.293
A125.24897.361.6−107.171.8176.2−179.4177.36.7004.7783.132
A135.137115.637.5−109.669.9168.6−72.0169.76.5004.9123.329
A143.804130.683.0−137.168.2−147.363.664.27.9164.9444.017
A153.851140.475.7−114.8−115.6140.7−61.663.47.6695.0823.917
A164.561120.166.8−112.470.5−178.363.960.57.5275.1033.411
A174.40099.734.4−112.067.257.844.948.36.2255.1394.217
A185.204119.339.3−110.769.8173.8−64.3−63.37.5125.2163.730
A193.41168.664.3−92.198.3−114.164.439.17.7605.3544.890
A204.387136.610.3−88.2158.879.4−71.0172.68.0425.3783.969
A213.562167.760.8−94.2−126.183.2−74.5178.06.3005.3844.494
A224.486118.567.8−112.870.8−179.771.7−171.98.0815.4323.764
A235.20988.551.3−104.577.391.3180.0−69.96.2185.4763.817
A244.381115.311.5−102.7−162.7−77.373.0−170.78.6855.5144.179
A254.94880.559.5−102.567.274.6176.3−68.26.4255.5884.277
A264.65580.078.1−99.574.6−104.0−175.272.47.0005.6334.093
A274.60983.178.2−102.271.5−107.6−174.8179.65.4735.6624.371
A285.146128.036.4−81.4−70.5−167.571.8−170.76.2295.6754.396
A294.65384.851.8−103.770.9−109.1−174.5−74.16.7315.8454.325
A305.23590.149.7−102.980.096.4179.4−173.87.8485.8504.085
A314.40099.734.4−112.067.257.844.948.36.2255.8904.508
A325.220123.338.2−81.4−70.2−172.664.664.84.3455.9094.708
A334.415114.112.6−104.1−163.1−74.669.369.47.3845.9174.782
A345.955104.431.3−95.4179.0−178.1179.272.96.0806.1744.503
A355.898124.030.3−96.6179.3179.3179.9179.66.6766.1954.544
A365.956124.331.3−96.4179.5178.1−179.0−72.97.7166.2544.762
A374.565102.434.8−112.666.460.556.3−178.87.6846.2905.085
A384.273110.272.9−105.871.1−103.2−66.6167.86.4586.4324.855
A394.970138.646.2−100.0−179.8172.1−72.6166.48.0716.6104.755
A405.011104.746.2−97.2−179.7−176.172.9−166.17.0236.7795.097
A415.030104.448.4−95.2179.6−177.964.361.58.2207.1005.519
A425.722115.419.7−99.3−176.9−84.1−179.270.46.4057.3725.289
A435.35087.645.5−90.3138.5−88.9−177.6−70.37.0077.4837.510
A445.38692.440.2−91.6146.1−91.1178.5173.87.1337.6275.567
A455.699118.818.3−101.1−173.8−84.4−178.6176.17.9947.6655.672
A465.765120.017.5−101.1−170.2−80.2−173.9−69.96.6807.6845.636
A474.832106.933.0−107.0−164.9−72.0−62.7178.18.5548.4516.636
B13.92873.453.475.1−146.795.5−68.872.85.8120.072
{3.885}{74.5}{50.3}{70.1}{−151.5}{94.2}{−68.1}{76.8}{6.204}{0.056}
3.88073.452.873.5−145.490.9−69.376.76.7460.0830.151
[3.927][73.6][53.1][74.4][−145.4][92.6][−69.8][74.6][5.485][0.124][0.822]
(3.855)(73.5)(55.6)(74.2)(−145.7)(90.5)(−68.9)(76.7)(5.595)(0.061)(0.108)
“3.870”“73.3”“51.1”“73.1”“−144.2”“89.6”“−70.0”“77.7”“5.374”“0.099”“0.195”
3.88273.752.774.0145.891.569.376.05.6010.0990.090
B23.77077.252.097.0−66.7−74.166.636.15.3481.216
{3.726}{17.9}{50.4}{95.6}{−66.8}{−75.8}{65.5}{44.0}{5.664}{0}l
2.90577.651.296.4−68.5−72.065.140.65.3400.871.251
[3.784][78.0][50.8][98.5][−68.9][−72.6][65.4][40.4][5.321][1.118][1.900]
(3.713)(77.3)(51.2)(96.8)(−68.2)(−72.4)(65.4)(39.9)(5.404)(0.612)(0.975)
“3.727”“77.5”“51.2”“96.2”“−68.4”“−72.9”“64.0”“39.8”“5.250”“0.968”“1.316”
3.73677.851.197.368.272.865.440.35.3980.9680.941
B35.157117.337.3106.1−71.7−171.163.5−57.65.9511.157
{5.007}{110.9}{37.4}{100.4}{−65.2}{−165.1}{60.9}{−53.8}{5.998}{2.179}
5.104117.936.2107.1−70.3−168.160.9−53.35.8392.2570.903
[5.149][120.9][35.9][111.5][−72.1][−168.6][62.9][−55.9][5.872][0.542][0]m
(5.080)(118.1)(36.5)(108.2)(−69.7)(−168.2)(60.8)(−53.3)(5.921)(1.748)(0.412)
“5.106”“119.5”“36.5”“108.6”“−71.3”“−169.7”“60.6”“−52.4”“5.814”“2.819”“1.394”
5.094118.636.6108.969.9168.461.754.75.9072.8190.001
B44.52995.565.478.370.8−178.763.6−54.46.4702.031
{3.673}{66.1}{78.5}{56.6}{63.8}{−147.2}{63.0}{−52.4}{6.649}{1.707}
3.81768.779.756.764.6−149.163.8−50.25.8702.7222.366
[4.300][85.9][70.0][69.9][70.9][−168.2][63.2][−52.1][6.144][1.331][0.867]
(3.814)(68.9)(79.4)(56.4)(64.5)(−150.0)(63.4)(−48.6)(5.913)(2.523)(2.080)
“3.839”“68.8”“79.2”“55.9”“65.4”“−150.2”“63.6”“−48.6”“5.680”“3.179”“2.791”
3.85870.378.658.064.6151.463.449.65.9493.1791.557
B54.598115.964.6105.4−72.8−178.2−64.956.77.9111.693
{4.507}{112.9}{64.3}{99.6}{−66.5}{−177.0}{−61.1}{52.8}{8.520}{2.832}
4.526117.564.8106.4−71.4180.0−62.052.87.7352.7571.463
[4.559][119.2][64.9][109.6][−73.3][179.7][−64.2][55.2][7.629][1.012][0.420]
(4.510)(118.4)(64.8)(107.6)(−70.7)−179.9(−61.8)(52.7)(7.826)(2.289)(0.978)
“4.524”“117.6”“64.7”“106.6”“−72.3”“−179.9”“−61.7”“52.1”“7.517”“3.262”“1.920”
4.524118.364.8107.671.1179.862.753.87.7933.2620.470
B65.119123.136.381.070.9170.1−60.754.15.4602.9932.035
B74.991113.329.3107.2−74.7−87.7−56.946.56.0273.6362.427
B83.582165.956.382.765.473.0−75.2178.46.4634.2403.708
B93.79370.479.157.268.0−93.9−49.860.85.0694.2633.900
B104.32599.229.198.3−88.0−94.769.5−166.28.2684.4963.334
B115.31899.261.7108.3−70.8−175.3179.671.15.6404.5083.006
B125.002132.029.177.574.788.457.0−46.25.2224.7913.824
B135.138115.037.3108.2−70.2−168.471.8−170.56.1334.8453.212
B145.24698.461.7108.6−71.5−176.6179.2177.16.5534.8523.244
B155.31299.262.1108.6−70.7−175.8−178.5−70.67.9644.8933.413
B164.40799.633.7110.2−68.1−57.9−44.6−48.75.9395.0424.065
B175.205118.239.0109.3−69.6−172.964.663.97.4295.1013.551
B183.562167.360.993.8125.8−83.074.6−178.06.0695.4564.582
B195.27789.949.5103.3−79.4−94.8−179.769.26.0545.5773.960
B204.87678.361.1101.0−65.9−75.2179.3−69.06.1025.6944.494
B215.25391.049.4103.8−80.2−97.6−178.6174.88.0345.9503.922
B224.534101.835.0112.6−66.2−59.3−55.7179.67.5596.1695.032
B233.14683.095.173.167.3−116.963.564.35.3346.3056.199
B244.61077.977.579.072.8−102.2−173.9−175.25.3176.6175.315
B254.365150.033.576.467.059.540.541.65.8826.6775.427
B264.618108.052.577.268.5−105.1−173.1−79.35.3086.6895.500
B275.184143.651.878.976.589.5−178.9−69.46.5636.7185.374
B284.635114.478.379.873.8−101.1−174.872.37.0316.8315.483
B295.194141.152.777.574.587.3175.368.05.2036.9975.596
B305.129142.952.379.176.590.0−179.5−175.27.0317.0155.609
B314.964136.432.277.271.078.864.1−178.95.0337.5086.051
a Notation used from ref. [49]; b ΔE = 0 = −811.214731 a.u. at B3LYP/6-311++G(3df,pd) level; c ΔE = 0 = −810.723396 a.u. at B3LYP/6-31G(d,p) level; d ΔG = 0 = −810.764701 a.u.;e ΔE = 0 = −810.449499 a.u. at O3LYP/6-31G(d,p) level; f ΔE = 0 = −810.419555 a.u. at B3LYP/cc-pVDZ level; g ΔG = 0 = −810.460766 a.u.; h ΔE = 0 = −810.760402 a.u. at B3PW91/6-31G(d,p) level; i ΔG = 0 = −810.801662 a.u.; j ΔE = 0 = −810.444324 a.u. at B972/6-31G(d,p) level; k ΔG = 0 = −810.485454 a.u.; l ΔE = 0 = −808.643998 a.u. at MP2/6-31G(d) level; m ΔG = 0 = −810.491798 a.u.
Table 3. Single point calculations at the MP2/6-31G(d,p)//B3LYP/6-31G(d,p) level.
Table 3. Single point calculations at the MP2/6-31G(d,p)//B3LYP/6-31G(d,p) level.
ConformerΔE/kcal·mol−1
A10.143
A20.082
A32.553
A43.112
B10.122
B20
B32.491
B41.962
B53.071
The conformers differ in general very little in energy. Thus, in our calculations 78 optimized conformers were found within the electronic energy range ΔE = 0–8.5 kcal/mol, and Gibbs energy range ΔG = 0–6.6 kcal/mol with respect to the global minimum. This range of values of ΔG is smaller than that calculated in dG, in dT [50], 0–7 kcal/mol and in dU [31], 0–9 kcal/mol.
Only four conformers are found within the electronic energy range ΔE = 0–1.0 kcal/mol (by criterium of ΔE + ZPE), Table 2, with φ1 −72°/−97° as g and 70°/96° as g+ by MP2. Among these conformers, B1 has the highest dipole moment 6.20 D although very close to that in A1, 6.18 D. These conformers are slightly favored in a polarizable environment with water.
Another seven conformers appear within the electronic energy range ΔE = 1.0–3.0 kcal/mol, three values were anti1 ca. −100°) and four syn1 ca. 90°). The anti structures are the expected forms in the natural nucleosides that form the nucleotides and polynucleotides in biological systems [33,35,46,47,48]. The ratio anti/syn in conformers A is 0.8 in the low-energy group (<3 kcal/mol) but it increases up to 1.7 in the 3.0–8.5 kcal/mol range.
The global minimum by DFT methods corresponds to the conformer denoted as A1 (Figure 4) and it appears stabilized by an intramolecular H-bond. The optimised bond lengths and natural NBO atomic charges on this conformer are collected in Figure 5. This global minimum by criterium of ΔE + ZPE agree well to that obtained by criterion of ΔG, but differs of that obtained by MP2/6-31G(d) and MP2/6-31G(d,p)//B3LYP/6-31G(d,p), Table 3 and Figure S3. It is because of the small difference in energy between both forms A1 and B2. This global minimum in the syn form by MP2 is in accordance to that obtained in other nucleosides [33,34,35] but differs of the anti form expected for the natural nucleosides and nucleotides in biological systems [43]. The second most stable conformer is B1 with values of φ1 = 70°, φ2 = −152° and φ3 = 94° by MP2.
Figure 4 shows the six best optimum conformers selected in the two ranges of φ1: three are A (A1–A3), and three are B (B1–B3). The values of the intramolecular H-bonds and the most important structural angles of each conformer are also included. Figure 6, Figure 7, Figure 8 and Figure 9 show the distribution of the 78 optimised conformers according to their energies, exocyclic torsional angles φ1–φ5, the angles β, Φ, and the vector R. The best significant conformers are pointed in these figures.
Figure 4. Geometry of the six most optimum conformers selected for each rotation angle φ1 determined in A1 conformer of N1 tautomer of acyclovir at B3LYP/6-31G(d,p) level. The values of the strongest intramolecular H-bonds are also included.
Figure 4. Geometry of the six most optimum conformers selected for each rotation angle φ1 determined in A1 conformer of N1 tautomer of acyclovir at B3LYP/6-31G(d,p) level. The values of the strongest intramolecular H-bonds are also included.
Pharmaceuticals 07 00695 g004
Figure 5. Natural atomic charges and optimum bond lengths in conformer B2 of tautomer N1 of acyclovir at B3LYP/6-31G(d,p) and MP2/6-31G(d,p) levels, in fuchsia and green colours, respectively.
Figure 5. Natural atomic charges and optimum bond lengths in conformer B2 of tautomer N1 of acyclovir at B3LYP/6-31G(d,p) and MP2/6-31G(d,p) levels, in fuchsia and green colours, respectively.
Pharmaceuticals 07 00695 g005
Figure 6. Distribution of the 78 optimum stable calculated conformers at the B3LYP/6-31G(d,p) level in tautomer N1 of acyclovir according to their exocyclic torsional angle φ1 and their: (a) relative electronic energy ΔE + ZPE correction; (b) relative Gibbs energy ΔG; and (c) the distance R. The most stable conformers of each type are pointed.
Figure 6. Distribution of the 78 optimum stable calculated conformers at the B3LYP/6-31G(d,p) level in tautomer N1 of acyclovir according to their exocyclic torsional angle φ1 and their: (a) relative electronic energy ΔE + ZPE correction; (b) relative Gibbs energy ΔG; and (c) the distance R. The most stable conformers of each type are pointed.
Pharmaceuticals 07 00695 g006
Figure 7. Distribution of the 78 optimum stable calculated conformers in tautomer N1 of acyclovir, according to the values of the exocyclic torsional angles: φ2. φ3. φ4 and φ5 versus the angle φ1.
Figure 7. Distribution of the 78 optimum stable calculated conformers in tautomer N1 of acyclovir, according to the values of the exocyclic torsional angles: φ2. φ3. φ4 and φ5 versus the angle φ1.
Pharmaceuticals 07 00695 g007
Figure 8. Distribution of the 78 optimum stable calculated conformers in tautomer N1 of acyclovir according to the values of the angles Φ and β, and the dipole moment μ versus the angle φ1.
Figure 8. Distribution of the 78 optimum stable calculated conformers in tautomer N1 of acyclovir according to the values of the angles Φ and β, and the dipole moment μ versus the angle φ1.
Pharmaceuticals 07 00695 g008
Figure 9. 3D plots with the relative energies of the 78 optimum stable conformers according to the values of the exocyclic torsional angles: φ1. φ2. φ3 and φ4 versus relative electronic energy ΔE + ZPE.
Figure 9. 3D plots with the relative energies of the 78 optimum stable conformers according to the values of the exocyclic torsional angles: φ1. φ2. φ3 and φ4 versus relative electronic energy ΔE + ZPE.
Pharmaceuticals 07 00695 g009

3.3. Conformational Angle Analysis

An overall examination of the five exocyclic torsional angles and two bond angles, defining the conformational space in tautomer N1 of ACV, leads to conclude the following, Figure 7, Figure 8 and Figure 9:
(i)
The dihedral angle φ1 presents a bimodal distribution: (−137° ≤ −74°) 47 conformers A (anti) and (57° ≤ 113°) 31 conformers B (syn). Anti forms prevail in number over syn ones and cover a slight wider range of φ1 values. This anti orientation has been found in the crystal of several nucleosides [51,52,53], and it is the form for biological activity [54]. Although, in many nucleoside analogues syn and anti forms have similar energy, however, the global minimum corresponds in general to the syn form, as in AZT [35]. In purine nucleosides there is relatively little restraint to rotation about the N9-C1' bond [55]. In ACV the high population of the anti forms and the wider range of φ1 values are factors that facilitate its antiviral activity. The sugar ring of the natural nucleoside dG can be mimics by the similar exocyclic angles of ACV
(ii)
The torsional φ2 angle has a clear bimodal distribution: 65° ≤ φ2 ≤ 180° (49 conformers, 34 are A and 15 are B) and –180° ≤ φ2 ≤ −66° (29 conformers, 13 are A and 16 are B), Figure 7
(iii)
The φ3 angle also has a bimodal conformation: 58° ≤ φ3 ≤ 180° (32 conformers, 22 are A and 10 are B) and −180° ≤ φ3 ≤ −58° (46 conformers, 25 are A and 21 are B)
(iv)
The φ4 angle has a trimodal distribution: −173° ≤ φ4 ≤ 175° (28 conformers, 16 are A and 12 are B), 41° ≤ φ4 ≤ 118° (28 conformers, 17 are A and 11 are B), and −75° ≤ φ4 ≤ −45° (22 conformers, 14 are A and 8 are B)
(v)
The torsional φ5 angle also has a trimodal distribution: −166° ≤ φ5 ≤ 165° (29 conformers, 19 A and 10 B), 39° ≤ φ5 ≤ 123° range (29 conformers, 16 A and 13 B), and −120° ≤ φ5 ≤ −46° (20 conformers, 12 A and 8 B)
(vi)
In the bond angle β has been observed a regular distribution in the 69° ≤ β ≤ 168° range, Figure 8. This large range indicates the high flexibility of the chain with multiple O5'H orientations. The most stable conformers with ΔE < 1 kcal·mol−1 have the β angle with values between 72° and 78°, while the conformers with higher ΔE have some values larger than 140°.
(vii)
The bond Φ angle also shows a regular distribution in the 10° ≤ Φ ≤ 83° range for conformers A, and 29° ≤ Φ ≤ 95° for conformers B. The value of this angle appears between 51° and 54° for the four best conformers with ΔE < 1 kcal/mol−1. In general, the most stable conformers do not have large values of Φ, neither low values.
Finally, the R vector has a large range of values, between 2.905Å and 5.956 Å, and it determines the distance of the OH end of the chain from the base plane.

3.4. Guanine Moiety

In the analysis of the six most stable conformers, the base heterocycle has a very small non-planarity, in general with torsional angles lower than 1°, with the exception of those involving N3 and N9 atoms with a value higher than 2°. It is due to the strong intramolecular H5'··N3 hydrogen bond which produces a ring deformation around N3. Thus, among the dihedral angles describing the base heterocycle nonplanarity, we have defined: ν0 (N1-C2=N3-C4), ν1 (C2=N3-C4=C5), ν2 (N3-C4=C5-C6), ν3 (N7=C8-N9-C4) and ν4 (C6-N1-C2=N3).
An analysis of the six most stable conformers (Figure 4) shows that the highest base heterocycle nonplanarity corresponds to conformer A2 with the torsional angles ν1 (2.8°), ν2 (−2.3°) and ν0 (−1.3°). The other conformers show deviations higher than 1° in the following torsional angles: Conformer A1 in ν2 (−1.2°) and ν3 (−1.1°), conformer A3 in ν1 (1.5°) and ν2 (−1.3°), conformer B1 in ν0 (1.3°) and ν1 (1.1°), and conformer B2 in ν4 (1.2°).
Comparing the bond lengths of ACV (conformer A1) with those of dG, it is observed that ACV has several bonds of the guanine moiety larger than the corresponding bonds in dG, while in the remaining bonds are smaller. The largest difference appears in C4-N3.

3.5. The Side Chain

The most important characteristic of the structure of ACV is the conformation of the side chain that is attached to N9, which is characterized by the exocyclic torsional angles φ1 to φ5, by the bond angles β and Φ that determine the position of the chain from the base, and by the distance R. The bonds along this chain can be in trans respect to each other and thus it gives an extended zig-zag structure or, by contrast, one or several alternate bonds can be in gauche in such a way that it resembles at least partially a portion of the furanose moiety of dG [49,56]. In this last case, it is capable of adopting conformations resembling a portion of the pentose ring, a factor which undoubtedly plays an important role in their biological activities [57]. Thus, three types of structures appear: two that have the side chain partially folded (conformers A and B), and one structure which has all bonds in trans orientation and leading to an almost planar zig-zag arrangement [49].

3.6. Intramolecular H-Bonds

Several authors have studied the intramolecular H-bonds in related nucleosides, in special using AIM method [58,59]. However, the absence of the furanose ring in ACV reduces largely the number of possible H-bonds. Therefore, only two intramolecular H-bonds may be observed in the main conformers of ACV: (i) The hydroxyl hydrogen H5'(O5') and the guanine’s position 3 nitrogen atom, H5'···N3, and (ii) The hydroxyl hydrogen H5'(O5') and the guanine’s position 2 oxygen atom, H5'···O2'.
Figure 4 shows these types of H-bonds in the six most stable conformers. H-bond (i) appears in conformers A1, B1, B2 and A2; while (ii) is observed in conformers B3 and A3 with values of 2.346 Å and 2.350 Å, respectively. H-bond (i) is stronger than (ii), and it gives a great stability to the structure. Thus, the conformers with the H-bond (i) are the most stable, ΔE < 1 kcal·mol−1, while the conformers with the H-bond (ii) have higher energy, ΔE > 2 kcal·mol−1.

3.7. Natural NBO Atomic Charges

The calculated values in conformer A1 appear collected in Figure 5. The largest negative charge corresponds to N2 and O5' atoms, −0.90 and −0.84 e, respectively by MP2 (where e is the charge of an electron). The next atom with large negative charge is N1 (ca. −0.7 e). The value of this charge is slightly higher than in dG, −0.69 e. The main effect of the NH2 group is a remarkable increment in the positive charge on C2, 0.81 e, because of the high negative charge on the amino nitrogen, −0.90 e. Consequently, a noticeable increase of the negative charge on N3 is observed, −0.73 e (−0.70 e in dG). The electron-rich sites of the guanine moiety are involved in H-bonds, with N3 and O2' acting as single acceptors.
In the nitrogen N9 the negative charge (−0.52 e) is lower than on N1, N3 and N7, but slightly higher than in dG. It is because in ACV the bonding to the chain increases the negative charge on N9. The value of the charge on N7 is important because in the neutral form of anti-tumour platinum drugs, the platinum atom has a strong preference for nitrogen N7 rather than for oxygen atoms of the base for its coordination [51]. Also, the N7 position in DNA is the most open to attack. N1 position is also important because when deprotonation of the weakly acid ACV occurs, the metal binding site changes to N1, which is the formally deprotonated site [60]. Raman spectra of related nucleosides in H2O indicate that the site of deprotonation in basic solutions is N1, while the site of protonation in acidic solutions is N3 and N7, the same sites that in its phosphorylated form. These results are useful for identification and characterization of its structure in natural occurring biopolymers [61].
The negative charge on the oxygen atoms is high, −0.65 e on O2' and −0.69 e on O6. The values in O2' and O5' are slightly higher than in dG, by B3LYP −0.603 e and −0.761 e, respectively. By contrast, in O6 the negative charge is lower than in dG, −0.592 e.
C6 is the atom with the highest positive charge, 0.829 e by MP2, in concordance to the high negative charge on O6, i.e., it is the most reactive. With a slightly lower value appears C2 (0.812 e), and with much lower values H5'(O5'), H1(N1), H2(N2) and H2'(N2). The remaining hydrogen atoms have much less positive charge and they are less reactive.

3.8. Solid State Simulation

The structure of ACV (CSD code CEHTAK) in the solid state was determined by X-ray diffraction [53,60,61,62,63]. Birnbaum et al. [49,62] obtained the crystals that belong to monoclinic space with three independent molecules (A, B and C), together with two water molecules [49]. Molecules A and B have similar conformation while that of molecule C is different, Table 4. In molecules A and B the angle φ1and φ2 are in the preferred g form, but in molecule C φ2 is in trans. It means that molecules A and B showed a partially folded conformation of the side chain, while molecule C appears extended [62]. Molecules A and B correspond to conformer A5 in the isolated state, while molecule C is represented by conformer A34. Molecules A and B are ca. 3 kcal·mol−1 more stable than molecule C. The difference in energy between molecule A and B is small and it is due to the flexibility of the side chains.
Table 4. A comparison of the most important structural parameters in the dimer and tetramer forms calculated at the B3LYP/6-31G(d,p) level in acyclovir molecule with those in the crystal. The torsional angles are in degrees and R in Å.
Table 4. A comparison of the most important structural parameters in the dimer and tetramer forms calculated at the B3LYP/6-31G(d,p) level in acyclovir molecule with those in the crystal. The torsional angles are in degrees and R in Å.
Solid formRβΦφ1φ2φ3φ4φ5
Dimer
Molecule A5.150127.9−82.1−82.1−70.4−168.471.9−168.8
Molecule B5.148127.9−88.8−88.8−70.3−168.171.8−168.9
Tetramer
Molecule A5.148128.6−82.3−82.3−70.4−167.372.5−167.4
Molecule B5.212117.2−80.1−80.1−76.3176.864.2−90.8
Molecule C5.110122.0158.6158.6−71.7−50.560.1−53.8
Molecule D4.313150.6−95.3−95.3−93.1−100.270.6−160.4
X-Ray [62]
Molecule A0 −76.5−76.9173.260.6
Molecule B −74.4−66.3−176.273.5
Molecule C −90.5−173.3−171.9−174.4
We have simulated this arrangement through a dimer and tetramer forms, Figure 10. The calculated value of the inter- and intramolecular H-bonds distances and the total energy is included in the Figure. The calculated bond lengths, bond angles and torsional angles are collected in Tables S1 and S2. The simulated structure is tightly bonded but not so tight as it the reported in the crystal. There are four donor sites: H1(N1), H2(N2), H2'(N2) and H5', and five possible acceptors: O6, N3, N7, O2' and O5'.
Figure 10. The optimized dimer and tetramer forms in conformer A1 of acyclovir at the B3LYP/6-31G(d,p) level. The H-bonds observed are in Å and the E (RB+HF-LYP) in a. u.
Figure 10. The optimized dimer and tetramer forms in conformer A1 of acyclovir at the B3LYP/6-31G(d,p) level. The H-bonds observed are in Å and the E (RB+HF-LYP) in a. u.
Pharmaceuticals 07 00695 g010
The dimer, and tetramer forms were built with the most stable conformer A1. In the dimer there are two intermolecular H-bonds between the two molecules: N1{in molecule A} and O6{in molecule B} 1.733 Å, and O6{in A} and N1{in B} 1.732 Å. The tetramer shows seven H-bonds: (i) two between molecule A and B: H(N1){in molecule A} and O6{in molecule B} 1.709 Å, and O6{in molecule A} and H(N1){in molecule B} 1.847 Å; (ii) There is only a H-bond between molecule B and C: H(O5´){in B} and N3{in C}, 1.945 Å; (iii) There are two H-bonds between molecule C and D: H(N1){in molecule C} and O6{in molecule D}, 1.741 Å, and O6{in C} and H(N1){in D}, 1.792 Å. (iv) At list there are two H-bonds between molecule D and B: N7{in molecule D} and H(N2'){in B}, 1.972 Å.
Comparing the calculated bond lengths and angles of molecule A in the dimer with the X-ray data [62], Tables S2 and S3, it is observed the good agreement in the values of our simulated structure. The greater differences appear in C4=C5 (0.025 Å), C2-N2 (0.023 Å), C3'-C4' and N1-C6 (0.016 Å), and the difference is almost null in C6=O, C5-N7, N7=C8 and C4-N9. A slight larger error is obtained when the comparison theory-experiment is carried out with the molecule B of the dimer. This error is slight reduced when the comparison is carried out with the simulated molecule A of the tetramer. In the angles the difference is almost null, with similar values of all the angles. Only several angles in the side chain show some noticeable differences, i.e., C3'-C4'-O5', 4.7°.
Other four anhydrous forms of ACV and a new hydrate have been characterized by X-ray diffraction, with significant differences in the intermolecular H-bonding networks among the ACV forms [63,64,65]. A study of the solution forms of ACV shows that ACV can exist as polymorphic and pseudopolymorphic solvates [66]. We have simulated other dimer, trimer and pentamer forms with different conformers and collected in Figure S4.

4. Conclusions

In the present work we have shown a comprehensive compendium of the possible conformers in tautomer N1 of ACV. The geometries and values of the properties presented here appear to the most accurate to date. The most important findings of the present work are the following:
(1)
Five tautomers of ACV were identified and fully optimized. At room temperature only tautomer N1 (48.1%), OHC (37.7%) and OHT (14.3%) have a noticeable population. It is very small in tautomers N3 and N7, less than 0.05%.
(2)
The relative energies of the five tautomers appear related to the dipole moment and to the torsional angle φ1. The least stable tautomer N3 in the isolated state has the highest μ and thus, it is the most favoured in a polarisable environment with water.
(3)
In the isolated state the most stable tautomer is N1 by both B3LYP and MP2 methods. In this tautomer, and through a rotation of φ1, φ2, φ3, φ4 and φ5 exocyclic torsional angles, 78 optimized stable conformers were identified, two syn and two anti failing into the 0–1 kcal·mol−1 ΔE + ZPE energy range.
(4)
The calculated most stable conformer by all DFT levels corresponds to A1, while by MP2 is B2. In the nitrogen atoms and in the O2' and O5' oxygen atoms of conformer A1 appear a higher reactivity than in the corresponding natural nucleoside deoxyguanosine.
(5)
The distribution of all the conformers according to the ranges of stability of the characteristic torsional angles was established. The values obtained indicate the flexible nature of ACV, which is higher than dG. An increase of the stability appears when the side chain is near to the purine base, with a value of R that fails into 3.925–2.892 Å range, and an angle Φ close to 54°.
(6)
Only two intramolecular H-bonds may be observed in the main conformers of ACV, in contrast to the six H-bond types calculated in dG. It leads to a flexibility higher in ACV than in dG.
(7)
The solid state was simulated through a dimer and tetramer forms. An excellent agreement with the X-ray crystal data was obtained, which indicates the good accuracy of the theoretical methods used.

Supplementary Files

  • Supplementary File 1:

    Supplementary Material (DOC, 618 KB)

  • Author Contributions

    This research corresponds to the PhD Thesis of M.C. Alvarez-Ros, in which M. Alcolea Palafox is the director.

    Conflicts of Interest

    The authors declare no conflict of interest.

    References

    1. Schloemer, G.C.; Han, Y.-K.; Harrington, P.J. Preparation of acyclovir using 1,3-dioxolane. U.S. Patent 5567816, 22 October 1996. [Google Scholar]
    2. Lazrek, H.B.; Baddi, L.; Smietana, M.; Vasseur, J.-J.; Sebti, S.; Zahouily, M. One-pot synthesis of antiviral acyclovir and other nucleosides derivatives using doped natural phosphate as Lewis acid catalyst. Nucleos. Nucleot. Nucleic Acids 2008, 27, 1107–1112. [Google Scholar] [CrossRef]
    3. Gao, H.; Mitra, A.K. Synthesis of acyclovir, ganciclovir and their prodrugs: A review. Synthesis 2000, 3, 329–351. [Google Scholar]
    4. De Clercq, E. Antiviral drugs: Current state of the art. J. Clinical Virol. 2001, 22, 73–89. [Google Scholar] [CrossRef]
    5. Emmert, D.H.; Lancaster, M.D. Treatment of common cutaneous herpes simplex virus infections. Am. Fam. Physician. 2000, 61, 1697–1607. [Google Scholar]
    6. Fuchs, J.; Celum, C.; Wang, J.; Hughes, J.; Sánchez, J.; Cowan, F.; Reid, S.; Delany-Moretlwe, S.; Corey, L.; Wald, A. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J. Infect Dis. 2010, 201, 1164–1168. [Google Scholar] [CrossRef]
    7. Piret, J.; Boivin, G. Resistance of herpes simplex viruses to nucleoside analogues: Mechanisms, prevalence, and management. Antimicrob. Agents Chemother. 2011, 55, 459–472. [Google Scholar] [CrossRef]
    8. Harnden, M.R.; Wyatt, P.G.; Boyd, M.R.; Sutton, D. Synthesis and antiviral activity of 9-alcoxypurines. 1.9-(3-hydroxypropoxy)- and 9-[3-hydroxy-2-(hydroxymethyl)propoxy]purines. J. Med. Chem. 1990, 33, 187–196. [Google Scholar] [CrossRef]
    9. Golankiewicz, B.; Ostrowski, T.; Goslinski, T.; Januszczyk, P.; Zeidler, J.; Baranowski, D.; de Clercq, E. Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study. J. Med. Chem. 2001, 44, 4284–4287. [Google Scholar] [CrossRef]
    10. Lisco, A.; Vanpouille, C.; Tchesnokov, E.P.; Grivel, J.C.; Biancotto, A.; Brichacek, B.; Elliott, J.; Fromentin, E.; Shattock, R.; Anton, P.; et al. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpes virus-infected human tissues. Cell Host Microbe. 2008, 4, 260–270. [Google Scholar] [CrossRef]
    11. Vanpouille, C.; Lisco, A.; Derudas, M.; Saba, E.; Grive, J.-C.; Brichacek, B.; Scrimieri, F.; Schinazi, R.; Schols, D.; McGuigan, C.; et al. A new class of dual-targeted antivirals: Monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2. J. Infect Dis. 2010, 201, 635–643. [Google Scholar] [CrossRef]
    12. Tanton, C.; Weiss, H.A.; LeGoff, J.; Changalucha, J.; Clayton, T.C.; Ross, D.A.; Belec, L.; Hayes, R.J.; Watson-Jones, D. Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania. Sex Transmit. Infect. 2011, 87, 406–411. [Google Scholar] [CrossRef]
    13. Delany, S.; Mlaba, N.; Clayton, T.; Akpomiemie, G.; Capovilla, A.; Legoff, J.; Belec, L.; Stevens, W.; Rees, H.; Mayaud, P. Impact of acyclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS. 2009, 23, 461–469. [Google Scholar] [CrossRef]
    14. Prichard, M.N.; Kern, E.R.; Hartline, C.B.; Lanier, E.R.; Quenelle, D.C. CMX001 Potentiates the efficacy of acyclovir in herpes simplex virus infections. Antimicrob. Agents Chemother. 2011, 55, 4728–4734. [Google Scholar]
    15. Kalachandra, S.; Takamata, T.; Lin, D.M.; Snyder, E.A.; Webster-Cyriaque, J. Stability and release of antiviral drugs from ethylene vinyl acetate (EVA) copolymer. J. Mater. Sci: Mater. Med. 2006, 17, 1227–1236. [Google Scholar] [CrossRef]
    16. Gavira, J.M.; de la Fuente, M.; Navarro, R.; Hernanz, A. Normal coordinate analysis of acycloguanosine. J. Molec. Struct. 1997, 410–411, 425–429. [Google Scholar]
    17. Birnbaum, G.I.; Johansson, N.G.; Shugar, D. Conformations of acyclonucleosides: Crystal structure of 9-(4-hydroxybutyl)guanine, an analogue of acyclovir. Nucleos. Nucleot. Nucleic Acids 1987, 6, 775–783. [Google Scholar] [CrossRef]
    18. Brandi-Blanco, M.P.; Choquesillo-Lazarte, D.; Domínguez-Martín, A.; González-Pérez, J.M.; Castiñeiras, A.; Niclós-Gutiérrez, J. Metal ion binding patterns of acyclovir: Molecular recognition between this antiviral agent and copper(II) chelates with iminodiacetate or glycylglycinate. J. Inorg. Biochem. 2011, 105, 616–623. [Google Scholar] [CrossRef]
    19. Barceló-Oliver, M.; Terrón, A.; García-Raso, A.; Fiol, J.J.; Molins, E.; Miravitlles, C. Ternary complexes metal [Co(II), Ni(II), Cu(II) and Zn(II)]–ortho-iodohippurate (I-hip)–acyclovir. X-ray characterization of isostructural [(Co, Ni or Zn)(I-hip)2(ACV)(H2O)3] with stacking as a recognition factor. J. Inorg. Biochem. 2004, 98, 1703–1711. [Google Scholar] [CrossRef]
    20. Brovarets, O.O.; Yurenko, Y.P.; Dubey, I.Y.; Hovorun, D.M. Can DNA-binding proteins of replisome tautomerize nucleotide bases? Ab initio model study. J. Biomol. Struct. Dyn. 2012, 29, 1101–1109. [Google Scholar] [CrossRef]
    21. Brovarets, O.O.; Hovorun, D.M. Prototropic tautomerism and basic molecular principles of hypoxanthine mutagenicity: An exhaustive quantum-chemical analysis. J. Biomol. Struct. Dyn. 2013, 31, 913–936. [Google Scholar] [CrossRef]
    22. Plass, M.; Kristl, A.; Abraham, M.H. Spectroscopic investigation of tautomeric equilibria in the guanine derivatives of acyclovir. J. Chem. Soc. Perkin Trans II 1999, 264, 26–41. [Google Scholar]
    23. Becke, A.D. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys. Rev. A 1988, 38, 3098–3100. [Google Scholar] [CrossRef]
    24. Becke, A.D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993, 98, 5648–5652. [Google Scholar] [CrossRef]
    25. Handy, N.C.; Cohen, A.J. Left-right correlation energy. Mol. Phys. 2001, 99, 403–412. [Google Scholar] [CrossRef]
    26. Hoe, W.-M.; Cohen, A.J.; Handy, N.C. Assessment of a new local exchange functional OPTX. Chem. Phys. Lett. 2001, 341, 319–328. [Google Scholar] [CrossRef]
    27. Xu, X.; Zhang, Q.; Muller, R.P.; Goddard III, W.A. An extended hybrid density functional (X3LYP) with improved descriptions of nonbond interactions and thermodynamic properties of molecular systems. J. Chem. Phys. 2005, 122, 14105–14114. [Google Scholar] [CrossRef]
    28. Lee, C.; Yang, W.; Parr, R.G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. 1988, B37, 785–789. [Google Scholar]
    29. Perdew, J.P.; Wang, Y. Accurate and simple analytic representation of electron-gas correlation energy. Phys. Rev. 1992, B45, 13244–13249. [Google Scholar] [CrossRef]
    30. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Montgomery, J.A., Jr.; Vreven, T.; Kudin, K.N.; Burant, J.C.; et al. Gaussian 03, Revision B.04; Gaussian Inc.: Pittsburgh, PA, USA, 2003.
    31. Yurenko, Y.P.; Zhurakivsky, R.O.; Ghomi, M.; Samijlenko, S.P.; Hovorun, D.M. Ab Initio comprehensive conformational analysis of 2′-deoxyuridine, the biologically significant DNA minor nucleoside, and reconstruction of its low- temperature matrix Infrared spectrum. J. Phys. Chem. B 2008, 112, 1240–1250. [Google Scholar] [CrossRef]
    32. Yurenko, Y.P.; Zhurakivsky, R.O.; Ghomi, M.; Samijlenko, S.P.; Hovorun, D.M. Comprehensive conformational analysis of the nucleoside analogue 2′-β-deoxy-6-azacytidine by DFT and MP2 calculations. J. Phys. Chem. B 2007, 111, 6263–6271. [Google Scholar]
    33. Alcolea Palafox, M.; Iza, N.; de la Fuente, M.; Navarro, R. Simulation of the first hydration shell of nucleosides D4T and Thymidine: structures obtained using MP2 and DFT methods. J. Phys. Chem. B 2009, 113, 2458–2476. [Google Scholar] [CrossRef]
    34. Alcolea Palafox, M.; Iza, N. Structure of the antiviral stavudine using quantum chemical methods: complete conformational space analysis, 3D potential energy surfaces and solid state simulation. J. Molec. Struct. 2012, 1028, 181–195. [Google Scholar]
    35. Alcolea Palafox, M.; Talaya, J. Hydration analysis of antiviral agent AZT by means of DFT and MP2 calculations. J. Phys. Chem. B 2010, 114, 15199–15211. [Google Scholar] [CrossRef]
    36. Alcolea Palafox, M.; Posada-Moreno, P.; Villarino-Marín, A.L.; Martinez-Rincon, C.; Ortuño-Soriano, I.; Zaragoza-García, I. DFT Calculation of four new potential agents muscarinic of bispyridinium type: structure, synthesis, biological activity, hydration, and relations with the potents W84 and DUO-3O. J. Comput. Aided Molec. Des. 2011, 25, 145–161. [Google Scholar] [CrossRef]
    37. Alcolea Palafox, M. Anticancer drug IUdR and other 5-halogen derivatives of 2′-deoxyuridine: conformers, hydrates and structure-activity relationships. Struct. Chem. 2014, 25, 53–69. [Google Scholar] [CrossRef]
    38. Alcolea Palafox, M.; Nielsen, O.F.; Lang, K.; Garg, P.; Rastogi, V.K. Geometry and vibrational spectra of 5-substituted uracils. Asian Chem. Letts. 2004, 8, 81–93. [Google Scholar]
    39. Alcolea Palafox, M.; Rastogi, V.K. Quantum Chemical predictions of the vibrational spectra of polyatomic molecules. The uracil molecule and two derivatives. Spectrochim. Acta. 2002, 58, 411–440. [Google Scholar] [CrossRef]
    40. Alcolea Palafox, M. The Prediction of Vibrational Spectra: The Use of Scale Factors. In Recent Research Developments in Physical Chemistry; Transworld Research Network: Trivandrum, India, 1998; Volume 2. [Google Scholar]
    41. Alcolea Palafox, M. Scaling factors for the prediction of vibrational spectra. I. Benzene molecule. Int. J. Quantum Chem. 2000, 77, 661–684. [Google Scholar] [CrossRef]
    42. Alcolea Palafox, M.; Iza, N.; Gil, M. The hydration effect on the uracil frequencies: an experimental and quantum chemical study. J. Molec. Struct. 2002, 585, 69–92. [Google Scholar] [CrossRef]
    43. Saenger, W. Principles in Nucleic Acid Structure; Springer Verlag: New York, NY, USA, 1984. [Google Scholar]
    44. Carpenter, J.E.; Weinhold, F. Analysis of the geometry of the hydroxymethyl radical by the “different hybrids for different spins” natural bond orbital procedure. J. Molec. Struct. 1988, 169, 41–62. [Google Scholar] [CrossRef]
    45. Wesolowski, T.A.; Godzik, A.; Geller, M. Calculations of the conformational properties of Acyclonucleosides. Part I. Stable conformations of acyclovir. Acta Biochim. Polonica. 1987, 34, 111–122. [Google Scholar]
    46. Tamara Molina, A.; Alcolea Palafox, M. Structure and conformational analysis of the anti-HIV AZT 5′-aminocarbonylphosphonate prodrug using DFT methods. Chem. Phys. 2011, 387, 11–24. [Google Scholar] [CrossRef]
    47. Alcolea Palafox, M. Molecular structure differences between the antiviral Nucleoside Analogue 5-iodo-2′-deoxyuridine and the natural nucleoside 2′-deoxythymidine using MP2 and DFT methods: Conformational analysis, crystal simulations, DNA pairs and possible behaviour. J. Biomol. Struct. Dyn. 2014, 32, 831–851. [Google Scholar] [CrossRef]
    48. Alcolea Palafox, M.; Iza, N. Tautomerism of the Natural Thymidine Nucleoside and in the Antiviral Analogue D4T. Structure and influence of an Aqueous Environment Using MP2 and DFT Methods. Phys. Chem. Chem. Phys. 2010, 12, 881–893. [Google Scholar] [CrossRef]
    49. Birnbaum, G.I.; Cygler, M.; Kusmierek, J.T.; Shugar, D. Structure and conformation of the potent antiherpes 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). Biochem. Biophys. Res. Comm. 1981, 103, 968–974. [Google Scholar] [CrossRef]
    50. Yurenko, Y.P.; Zhurakivsky, R.O.; Ghomi, M.; Samijlenko, S.P.; Hovorun, D.M. How many conformers determine the thymidine low-temperature matrix infrared spectrum? DFT and MP2 quantum chemical study. J. Phys. Chem. B. 2007, 111, 9655–9663. [Google Scholar] [CrossRef]
    51. Parthasarathy, R.; Kim, H. Conformation and sandwiching of bases by azido groups in the crystal structure of 3′-azido-3′-deoxy-thymidine (AZT), an antiviral agent that inhibits HIV reverse transcriptase. Biochem. Biophys. Res. Comm. 1988, 152, 351–358. [Google Scholar] [CrossRef]
    52. Camerman, A.; Mastropaolo, D.; Camerman, N. Azidothymidine: crystal structure and possible functional role of the azido group. Proc. Natl. Acad. Sci. USA 1987, 84, 8239–8242. [Google Scholar] [CrossRef]
    53. Dyer, I.; Low, J.N.; Tollin, P.; Wilson, H.R.; Howie, R.A. Structure of 3′-deoxythymidine, AZT. Acta Crystallog. 1988, C44, 767–769. [Google Scholar]
    54. Painter, G.R.; Andrews, C.W.; Furman, P.A. Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state. Nucleos. Nucleot. Nucleic Acids. 2000, 19, 13–29. [Google Scholar] [CrossRef]
    55. Thewalt, U.; Bugg, C.E.; Marsh, R.E. The crystal structure of guanosine dihydrate and inosine dihydrate. Acta Cryst. 1970, B26, 1089–1101. [Google Scholar] [CrossRef]
    56. Kazimierczuk, Z.; Stolarski, R.; Shugar, D. Acyclonucleosides: acyclobenzimidazole nucleoside and nucleotide analogues and conformations of the acyclic chains by means of NMR spectroscopy. Acta Biochim. Polonica. 1984, 31, 33–48. [Google Scholar]
    57. Birnbaum, G.I.; Stolarski, R.; Kazimierczuk, Z.; Shugar, D. Solid state and solution conformations of 1-(β-d-2′-3′-secoribofuranosyl)-5,6-dichlorobenzimidazole, an acyclonucleoside analogue. Can. J. Chem. 1985, 63, 1215–1221. [Google Scholar] [CrossRef]
    58. Fidanza, N.G.; Sosa, G.L.; Lobayan, R.M.; Peruchena, N.M. Topological analysis of the electronic charge density in nucleoside analogues derivatives of the AZT. Effects of X–H⋯O and X–H⋯F intramolecular H-bonds. J. Molec. Struct. 2005, 722, 65–78. [Google Scholar] [CrossRef]
    59. Yurenko, Y.P.; Zhurakivsky, R.O.; Samijlenko, S.P.; Hovorun, D.M. Intramolecular CH...O hydrogen bonds in the A1 and B1 DNA-like conformers of canonical nucleosides and their Watson-Crick pairs. Quantum chemical and AIM analysis. J. Biomol. Struct. Dyn. 2011, 29, 51–65. [Google Scholar] [CrossRef]
    60. Klüfers, P.; Mayer, P. The sodium salt of N1-deprotonated inosine, Na+.C10H11N4O5−.2.5H2O. Acta Crystallogr. 1996, C52, 2970–2972. [Google Scholar]
    61. Medeiros, G.C.; Thomas, G.-J., Jr. Raman studies of nucleic acids IV. Vibrational spectra and associative interactions of aqueos inosine derivatives. Biochim. Biophys. Acta 1971, 247, 449–462. [Google Scholar] [CrossRef]
    62. Birnbaum, G.I.; Cygler, M.; Shugar, D. Conformational features of acyclonucleosides: structure of acyclovir, an antiherpes agent. Can. J. Chem. 1984, 62, 2646–2652. [Google Scholar] [CrossRef]
    63. Lutker, K.M.; Quiñones, R.; Xu, J.; Ramamoorthy, A.; Matzger, A.J. Polymorphs and hydrates of acyclovir. J. Pharm. Sci. 2011, 100, 949–963. [Google Scholar] [CrossRef]
    64. Sohn, Y.T.; Kim, S.H. Polymorphism and pseudopolymorphism of acyclovir. Arch. Pharm. Res. 2008, 31, 231–234. [Google Scholar] [CrossRef]
    65. Barboza, F.; Vecchia, D.D.; Tagliari, M.P.; Silva, M.A.S.; Stulzer, H.K. Differential scanning calorimetry as a screening technique in compatibility studies of acyclovir extended release formulations. Pharm. Chem. J. 2009, 43, 363–368. [Google Scholar] [CrossRef]
    66. Kristl, A.; Srčič, S.; Vrečer, F.; Šuštar, B.; Vojnovic, D. Polymorphism and pseudopolymorphism: Influencing the dissolution properties of the guanine derivative acyclovir. Int. J. Pharm. 1996, 139, 231–235. [Google Scholar] [CrossRef]

    Share and Cite

    MDPI and ACS Style

    Alvarez-Ros, M.C.; Palafox, M.A. Conformational Analysis, Molecular Structure and Solid State Simulation of the Antiviral Drug Acyclovir (Zovirax) Using Density Functional Theory Methods. Pharmaceuticals 2014, 7, 695-722. https://doi.org/10.3390/ph7060695

    AMA Style

    Alvarez-Ros MC, Palafox MA. Conformational Analysis, Molecular Structure and Solid State Simulation of the Antiviral Drug Acyclovir (Zovirax) Using Density Functional Theory Methods. Pharmaceuticals. 2014; 7(6):695-722. https://doi.org/10.3390/ph7060695

    Chicago/Turabian Style

    Alvarez-Ros, Margarita Clara, and Mauricio Alcolea Palafox. 2014. "Conformational Analysis, Molecular Structure and Solid State Simulation of the Antiviral Drug Acyclovir (Zovirax) Using Density Functional Theory Methods" Pharmaceuticals 7, no. 6: 695-722. https://doi.org/10.3390/ph7060695

    Article Metrics

    Back to TopTop